" A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RECOMBINANT HUMAN PLASMA GELSOLIN (RHU-PGSN) ADDED TO STANDARD OF CARE FOR TREATMENT OF SUBJECTS WITH SEVERE COVID-19 PNEUMONIA" PROTOCOL CODE BTI-202


Tabla resumen
 Institución: URV Tipo: Transferencia
 Ámbito: Europeo Duración: 24/07/2020 - 25/07/2021
 Miembros: 13 IP: Hombre
 Fondos: 160576,80 Descripción: Europeo